PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Biochemistry, Hadassah-Hebrew University, Jerusalem, Israel.\', \'Heart Institute, Hillel Yaffe Medical Center Affiliated with Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.\', \'Departments of Pathology and Laboratory Medicine, Philadelphia, PA, USA.\', \'Medicine, University of Pennsylvania-Perelman School of Medicine, Philadelphia, PA, USA.\', \'Department of Medicine, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bjh.17885
?:hasPublicationType
?:journal
  • British journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 34622440
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.036
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all